chevron_leftBack
K
As of 20 June 2026, KALA BIO, Inc. has a market cap of $67.11M USD, ranking #28401 globally and #4276 in the United States.
It ranks #2570 in the Healthcare sector, and #917 in the Drug Manufacturers - General industry.
Key Stats
Market Cap
$67.11MUSD
Company Profile
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| 27% | 54% | 30% | -71% | -87% | -98% |
News
Loading...
KALA Analyst Forecasts
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
KALA
ISIN: US4831193010
Shares Out.:
Shares Outstanding:
18.59M1
Shares Float:
18.556M2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
NQ:
NASDAQ:
BA:
Barron's:
MS:
Morningstar:
|
3.61 USD | |
|
0JQ2
ISIN: US4831193010
|
3.38 USD |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NYSE: LLY
|
$761.68B
1M%
|
38.1
|
|
NYSE: JNJ
|
$547.28B
815K%
|
26.4
|
|
NYSE: ABBV
|
$360.63B
537K%
|
97.4
|
|
NYSE: MRK
|
$274.03B
408K%
|
15.1
|
|
NYSE: PFE
|
$149.38B
222K%
|
19.5
|
|
NYSE: BMY
|
$117.58B
175K%
|
16.8
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
SIX: RO
|
$318.3B
474K%
256.25B CHF
|
19.9
|
|
LSE: AZN
|
$284.64B
424K%
215.59B GBP
|
27.6
|
|
SIX: NOVN
|
$271.9B
405K%
218.9B CHF
|
20.5
|
|
CPH: NOVO-B
|
$180.26B
269K%
1.18T DKK
|
11.5
|
|
EPA: SAN
|
$109.16B
163K%
95.26B EUR
|
19.9
|
|
LSE: GSK
|
$106.89B
159K%
80.96B GBP
|
14.6
|
chevron_leftBack